1. Home
  2. PTEN vs OCUL Comparison

PTEN vs OCUL Comparison

Compare PTEN & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patterson-UTI Energy Inc.

PTEN

Patterson-UTI Energy Inc.

HOLD

Current Price

$10.80

Market Cap

2.2B

Sector

Energy

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$8.33

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTEN
OCUL
Founded
1978
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
PTEN
OCUL
Price
$10.80
$8.33
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$8.00
$22.90
AVG Volume (30 Days)
9.9M
6.0M
Earning Date
04-22-2026
05-04-2026
Dividend Yield
3.72%
N/A
EPS Growth
90.16
N/A
EPS
N/A
N/A
Revenue
$4,826,624,000.00
$1,990,000.00
Revenue This Year
N/A
$9.35
Revenue Next Year
$3.36
$92.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.48
52 Week Low
$5.10
$6.23
52 Week High
$10.87
$16.44

Technical Indicators

Market Signals
Indicator
PTEN
OCUL
Relative Strength Index (RSI) 82.08 39.37
Support Level $5.26 $6.23
Resistance Level N/A $12.20
Average True Range (ATR) 0.42 0.62
MACD 0.13 -0.13
Stochastic Oscillator 84.67 0.62

Price Performance

Historical Comparison
PTEN
OCUL

About PTEN Patterson-UTI Energy Inc.

Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: